12/02/2025
Dry Age-Related Macular Degeneration remains one of the leading causes of central vision loss worldwide, yet early signs often go unnoticed without regular examination.
Our new blog explores the importance of early detection, key risk factors, and emerging approaches to Dry AMD management. We also highlight developments in non-invasive therapy, including Neurostimulation and Microcurrent Stimulation techniques such as MacuMira, a device recently introduced in Australia and New Zealand via our partner MacuMira and exclusive distributor, ParagonCare.
With advanced diagnostic tools and growing evidence in novel treatment pathways, this evolving landscape underscores the value of continued clinical education in supporting patient outcomes.
Discover more at https://www.keelerglobal.com/understanding-and-managing-dry-amd-a-new-era-in-treatment/?utm_campaign=macumira&utm_source=organic&utm_medium=blog for a deeper look at current research and emerging practice trends.